Article
Pharmacology & Pharmacy
Shiwen Xu, Chunyan Yu, Xiaoxia Ma, Yan Li, Yangyang Shen, Yan Chen, Suhui Huang, Tongshuo Zhang, Weimin Deng, Yue Wang
Summary: IL-6 enhances the chemoresistance of ovarian cancer cells against cisplatin by facilitating the nuclear translocation of HIF-1 alpha via the STAT3 signaling pathway, both in in vitro and in vivo studies.
EUROPEAN JOURNAL OF PHARMACOLOGY
(2021)
Article
Food Science & Technology
M. L. Cuellar-Nunez, E. Gonzalez de Mejia, G. Loarca-Pina
Summary: Moringa oleifera leaves have shown chemopreventive properties against inflammatory response and colon carcinogenesis by modulating gene expression and reducing proinflammatory mediators.
FOOD RESEARCH INTERNATIONAL
(2021)
Review
Health Care Sciences & Services
Hina Amer, Apriliana E. R. Kartikasari, Magdalena Plebanski
Summary: The study revealed that IL6 levels in the blood were significantly higher in ovarian cancer patients than in healthy controls, but not significantly higher than those with benign ovarian growths. The levels of IL6 in ascites were also significantly elevated in both late-stage and early-stage OC. Ascitic IL6 showed higher sensitivity in early detection of OC.
JOURNAL OF PERSONALIZED MEDICINE
(2021)
Article
Cell Biology
Mengyuan Liu, Heming Li, Huijing Zhang, Huan Zhou, Taiwei Jiao, Mingliang Feng, Fangjian Na, Mingjun Sun, Mingfang Zhao, Lei Xue, Lu Xu
Summary: By analyzing high-throughput sequencing datasets, this study identified RBMS1 as a potential promoter gene for gastric cancer metastasis, which activates the JAK2/STAT3 signaling pathway and IL-6 transcriptional activation, promoting cell migration and invasion.
CELL DEATH & DISEASE
(2022)
Article
Oncology
Michela Lupia, Valentina Melocchi, Francesca Bizzaro, Pietro Lo Riso, Elisa Dama, Micol Baronio, Alberto Ranghiero, Massimo Barberis, Loris Bernard, Giovanni Bertalot, Raffaella Giavazzi, Giuseppe Testa, Fabrizio Bianchi, Ugo Cavallaro
Summary: High-grade serous ovarian carcinoma (HGSOC) is a highly aggressive and intractable tumor with unknown molecular alterations. Researchers identified molecular changes associated with HGSOC and identified potential vulnerabilities associated with the tumor. The PI3K signaling pathway was identified as a novel druggable target in OCSC.
INTERNATIONAL JOURNAL OF CANCER
(2022)
Article
Immunology
Huan Yi, Yan-zhao Su, Rong Lin, Xiang-qin Zheng, Diling Pan, Dan-mei Lin, Xiang Gao, Rong Zhang
Summary: The study suggests that high expression of RIPK4 in ovarian cancer is associated with poorer overall survival, and downregulation of RIPK4 can inhibit EMT by suppressing IL-6, providing a new therapeutic target for improving the prognosis of ovarian cancer patients.
JOURNAL OF IMMUNOLOGY RESEARCH
(2021)
Article
Cell Biology
Purvi Purohit, Dipayan Roy, Shailendra Dwivedi, Naresh Nebhinani, Praveen Sharma
Summary: The study found that individuals with chronic opioid use disorder had elevated levels of inflammatory cytokines TNF-alpha and IL-10, while IL-6 was reduced. There was a dose-dependent upregulation of miR-155-5p and miR-187-5p at opium doses greater than 1500 g/month, along with an increase in TNF-alpha and IL-10.
Article
Endocrinology & Metabolism
Jiatong Zhou, Haojie Chen, Yanyuan Wu, Bowen Shi, Jie Ding, Jun Qi
Summary: This study investigates the impact of inflammatory markers, such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha), on Gleason score (GS) changes in patients with prostate cancer (PCa) after radical prostatectomy (RP). The results suggest that high levels of serum TNF-alpha are associated with GS upgrade, while high levels of serum IL-6 are negatively correlated with GS upgrade and positively correlated with GS downgrade in PCa patients.
Article
Endocrinology & Metabolism
Kangkang Huang, Yunlai Liang, Yating Ma, Jiahui Wu, Huidan Luo, Bin Yi
Summary: This study discovered significant variations in adiponectin, nesfatin-1, IL-6, and TNF-alpha levels among healthy individuals, prediabetic patients, and type 2 diabetes mellitus patients, indicating a gradual change during the progression from a healthy condition to diabetes via prediabetes.
FRONTIERS IN ENDOCRINOLOGY
(2022)
Article
Pharmacology & Pharmacy
Himangshu Sonowal, Hongying Zhang, William Rice, Stephen B. Howell
Summary: The multikinase inhibitor Luxeptinib demonstrates the ability to inhibit the release of IL-1 beta, IL-6, and TNF alpha from monocytes and macrophages, making it a potential treatment for inflammatory diseases and inflammation-associated resistance in cancer. The mechanism involves disabling caspase-1 and inhibiting multiple kinases.
BIOCHEMICAL PHARMACOLOGY
(2022)
Article
Immunology
Nikolaos Skartsis, Yani Peng, Leonardo M. R. Ferreira, Vinh Nguyen, Emilie Ronin, Yannick D. Muller, Flavio Vincenti, Qizhi Tang
Summary: The study shows that human Tregs respond positively to proinflammatory cytokines, enhancing proliferation without affecting their lineage identity or function, providing a potential method for therapeutic Treg manufacturing.
FRONTIERS IN IMMUNOLOGY
(2021)
Article
Cell Biology
Areej Al-Roub, Ashraf Al Madhoun, Nadeem Akhter, Reeby Thomas, Lavina Miranda, Texy Jacob, Ebaa Al-Ozairi, Fahd Al-Mulla, Sardar Sindhu, Rasheed Ahmad
Summary: The overexpression of IL-6 in the adipose tissue of obese individuals may lead to insulin resistance. IL-1 beta and TNF alpha, which are increased in obese adipose tissue, cooperate to enhance the production of IL-6 in adipocytes. This cooperative interaction depends on CREB binding and H3K14 acetylation and provides an interesting pathophysiological connection among IL-1 beta, TNF alpha, and IL-6 in obesity settings.
Article
Immunology
Alexandria Lozowchuk, Judith E. Carroll, Calvin Hobel, Mary Coussons-Read, Christine Dunkel Schetter, Kharah M. Ross
Summary: This study explored the relationship between partner relationship quality and inflammatory markers IL-6, IL-10, and TNF-alpha during pregnancy and the postpartum period. The findings suggest that lower partner support may be associated with reduced inflammation regulation, with potential consequences for maternal health and well-being.
BRAIN BEHAVIOR AND IMMUNITY
(2023)
Review
Chemistry, Medicinal
Alvaro Nobrega de Melo Madureira, Joao Ricardhis Saturnino de Oliveira, Vera Lucia de Menezes Lima
Summary: Interleulcin-6 (IL-6) is a myokine that can be released by exercising skeletal muscle. It activates the PI3K-Akt pathway to enhance insulin signaling and glycogen synthesis. IL-6 also increases GLUT-4 vesicle mobilization and may contribute to muscle hypertrophy by activating mTORC1 and promoting contractile protein synthesis.
MINI-REVIEWS IN MEDICINAL CHEMISTRY
(2022)
Article
Neurosciences
Donna L. Gruol, Delilah Calderon, Katharine French, Claudia Melkonian, Salvador Huitron-Resendiz, Chelsea Cates-Gatto, Amanda J. Roberts
Summary: The neuroimmune system of the brain, primarily composed of astrocytes and microglia, regulates homeostatic mechanisms crucial for normal brain function. Alcohol consumption and neuroimmune factors, such as proinflammatory cytokines IL-6 and TNF-alpha, disrupt this regulation by acting on common targets in the brain. Recent studies suggest that IL-6 plays a role in alcohol drinking and its effects on brain activity, but more research is needed.
Article
Oncology
Kelly L. Singel, Kassondra S. Grzankowski, A. N. M. Nazmul H. Khan, Melissa J. Grimm, Anthony C. D'Auria, Kayla Morrell, Kevin H. Eng, Bonnie Hylander, Paul C. Mayor, Tiffany R. Emmons, Nikolett Lenart, Rebeka Fekete, Zsuzsanna Kornyei, Uma Muthukrishnan, Jonathan D. Gilthorpe, Constantin F. Urban, Kiyoshi Itagaki, Carl J. Hauser, Cynthia Leifer, Kirsten B. Moysich, Kunle Odunsi, Adam Denes, Brahm H. Segal
BRITISH JOURNAL OF CANCER
(2019)
Article
Oncology
Devalingam Mahalingam, Grey A. Wilkinson, Kevin H. Eng, Paul Fields, Patrick Raber, Jennifer L. Moseley, Karol Cheetham, Matt Coffey, Gerard Nuovo, Pawel Kalinski, Bin Zhang, Sukeshi Patel Arora, Christos Fountzilas
CLINICAL CANCER RESEARCH
(2020)
Article
Biochemistry & Molecular Biology
Swati Venkat, Arwen A. Tisdale, Johann R. Schwarz, Abdulrahman Alahmari, H. Carlo Maurer, Kenneth Olive, Kevin H. Eng, Michael E. Feigin
Article
Oncology
Anm Nazmul H. Khan, Tiffany R. Emmons, Jerry T. Wong, Emad Alqassim, Kelly L. Singel, Jaron Mark, Brandon E. Smith, Joseph D. Tario, Kevin H. Eng, Kirsten B. Moysich, Kunle Odunsi, Scott I. Abrams, Brahm H. Segal
CANCER IMMUNOLOGY RESEARCH
(2020)
Meeting Abstract
Oncology
S. Lynam, F. O. Recio, M. Roy, S. Belliotti, S. N. Akers, P. J. Frederick, S. B. Lele, E. Zsiros, K. H. Eng, K. Odunsi
GYNECOLOGIC ONCOLOGY
(2020)
Article
Oncology
Ashley Mussell, He Shen, Yanmin Chen, Michalis Mastri, Kevin H. Eng, Wiam Bshara, Costa Frangou, Jianmin Zhang
Article
Biology
Justin Zonneville, Moyi Wang, Mohammed M. Alruwaili, Brandon Smith, Megan Melnick, Kevin H. Eng, Thomas Melendy, Ben Ho Park, Renuka Iyer, Christos Fountzilas, Andrei Bakin
Summary: Zonneville et al. demonstrate that p53 mutant cancers with high replication activity and BER pathway expression can be targeted using a combination of fluorinated deoxyuridine analogues and PARP inhibitors, resulting in DNA damage induction and tumor growth suppression in mice. This study highlights a novel selective combination therapy strategy for p53 mutant cancers that shows a greater anti-neoplastic efficacy compared to monotherapy.
COMMUNICATIONS BIOLOGY
(2021)
Article
Oncology
James Ellegate, Michalis Mastri, Emily Isenhart, John J. Krolewski, Gurkamal Chatta, Eric Kauffman, Melissa Moffitt, Kevin H. Eng
Summary: The MAGEC3 gene is found to be lost in ovarian cancers, and its loss is associated with better survival rate. The MAGEC3 protein is also correlated with immune-related features and DNA repair pathway expression. Therefore, MAGEC3 is considered a prognostic biomarker in ovarian cancer.
Article
Oncology
Chetan C. Oturkar, Nishant Gandhi, Pramod Rao, Kevin H. Eng, Austin Miller, Prashant K. Singh, Emese Zsiros, Kunle O. Odunsi, Gokul M. Das
Summary: High grade serous ovarian cancer (HGSOC) is a common and deadly subtype of ovarian cancer with a high prevalence of mutant p53. This study investigated the interaction between estrogen receptor-beta (ER beta) and mutant p53 in HGSOC. The researchers found that ER beta 2 and mutant p53 co-dependently regulated the transcription of the FOXM1 gene, leading to increased cell proliferation and resistance to treatment. High levels of ER beta 2 and FOXM1 were correlated with worse patient survival. This suggests that targeting the ER beta 2-mutant p53-FOXM1 axis could be a novel therapeutic strategy for HGSOC.
Article
Oncology
Emmanuel B. Omole, Iqbal Aijaz, James Ellegate, Emily Isenhart, Mohamed M. Desouki, Michalis Mastri, Kristen Humphrey, Emily M. Dougherty, Spencer R. Rosario, Kent L. Nastiuk, Joyce E. Ohm, Kevin H. Eng
Summary: The study revealed a weak inverse correlation between the expression of MAGEC3 and BRCA2 in epithelial ovarian cancer, suggesting that the combined expression of MAGEC3 and BRCA2 may serve as a better predictor of prognosis than each marker alone.
Meeting Abstract
Immunology
Sora Suzuki, Thejaswini Giridharan, A. N. M. Nazmul Khan, Tiffany R. Emmons, Michael B. Yaffe, Kipp Weiskopf, Madhumita Das, Kevin H. Eng, Emese Zsiros, Brahm H. Segal
JOURNAL OF IMMUNOLOGY
(2022)
Meeting Abstract
Oncology
Justin Zonneville, Moyi Wang, Mohammed Alruwaili, Kevin Eng, Thomas Melendy, Ben Ho Park, Renuka Iyer, Christos Fountzilas, Andrei V. Bakin
Meeting Abstract
Oncology
Yuhao Shi, Melissa Dolan, Michalis Mastri, James W. Hill, Kevin Eng, John M. Ebos
Article
Medicine, Research & Experimental
Chunliu Pan, Neha Jaiswal Agrawal, Yanni Zulia, Shalini Singh, Kai Sha, James L. Mohler, Kevin H. Eng, Joe Chakkalakal, John J. Krolewski, Kent L. Nastiuk
Article
Medicine, Research & Experimental
Kelly L. Singel, Tiffany R. Emmons, A. N. M. Nazmul H. Khan, Paul C. Mayor, Shichen Shen, Jerry T. Wong, Kayla Morrell, Kevin H. Eng, Jaron Mark, Richard B. Bankert, Junko Matsuzaki, Richard C. Koya, Anna M. Blom, Kenneth R. McLeish, Jun Qu, Sanjay Ram, Kirsten B. Moysich, Scott Abrams, Kunle Odunsi, Emese Zsiros, Brahm H. Segal
Article
Oncology
Dimitrios Nasioudis, Stefan Gysler, Nawar Latif, Lory Cory, Robert L. Giuntoli II, Sarah H. Kim, Fiona Simpkins, Lainie Martin, Emily M. Ko
Summary: The prevalence of ERBB2 gene amplification was investigated among patients with gynecologic malignancies. The study found that ERBB2 amplification is frequently encountered in uterine serous carcinoma and mucinous ovarian carcinoma, but less common in endometrioid endometrial carcinoma.
GYNECOLOGIC ONCOLOGY
(2024)